Issues
-
Cover image
Cover Image
Cover: Subretinal fibrotic lesion labeled with GFP-positive pericytes (green) originated from the choroid and fibronectin (red), an extracellular matrix component (nuclei labeled with DAPI, blue). See article by Luo et al. (dmm032060). Cover image is licensed under a Creative Commons Attribution 4.0 International license.
- PDF Icon PDF LinkTable of contents
- PDF Icon PDF LinkIssue info
AT A GLANCE
A peek into cancer-associated fibroblasts: origins, functions and translational impact
Summary: Cancer-associated fibroblasts constitute a functionally heterogeneous mesenchymal cell population in the tumor microenvironment. This ‘At a glance’ article reviews their origin and their pro- and antitumor properties.
REVIEW
Animal models for bone tissue engineering and modelling disease
Summary: This Review describes the currently used animal models of critical-sized bone defects and the regenerative bone tissue engineering strategies used in these models, as well as the application of bone tissue engineering for the advancement of cancer xenograft models.
RESEARCH ARTICLES
CD40-mediated HIF-1α expression underlying microangiopathy in diabetic nerve pathology
Summary: This study provides a new therapeutic strategy for diabetic neuropathy, by demonstrating CD40 as a key mediator of microangiopathy leading to HIF-1α expression in endothelial cells.
Daunorubicin reduces MBNL1 sequestration caused by CUG-repeat expansion and rescues cardiac dysfunctions in a Drosophila model of myotonic dystrophy
Summary: MBNL protein sequestration by expanded CUG RNA contributes towards cardiac dysfunction in a myotonic dystrophy Drosophila model. Here, the authors identify the anticancer drug daunorubicin as a candidate therapeutic for the disease.
Choroidal pericytes promote subretinal fibrosis after experimental photocoagulation
Summary: Using a laser-induced photocoagulation model with collagen 1α1-GFP reporter mice, we identified choroidal pericytes as potential therapeutic targets to prevent subretinal fibrosis for management of neovascular age-related macular degeneration.
Sporadic amyotrophic lateral sclerosis (SALS) – skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model
Editor's choice: In amyotrophic lateral sclerosis, a motor neurodegenerative disease, the pathological changes of the skeletal muscle can significantly damage motor neurons, leading to progressive neurodegeneration.
RESOURCE ARTICLES
Truncated C-terminus of fibrillin-1 induces Marfanoid-progeroid-lipodystrophy (MPL) syndrome in rabbit
Summary: A novel genetically engineered rabbit model of MPL syndrome, generated by CRISPR/Cas9-mediated mutation of FBN1, mimics the histopathological changes and functional defects of MPL syndrome seen in the clinic.
Generation of a double binary transgenic zebrafish model to study myeloid gene regulation in response to oncogene activation in melanocytes
Summary: The authors present an innovative double binary zebrafish model for exploring regulatory mechanisms that govern the myeloid response at the onset of melanoma.
Call for papers – In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery

We invite you to submit your latest research to our upcoming special issue: In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery, coordinated by DMM Editor Vivian Li (The Francis Crick Institute, London, UK), alongside Guest Editors Austin Smith (University of Exeter, UK) and Joseph Wu (Stanford University School of Medicine, USA).The deadline for submitting articles is 6 October 2025.
The Company of Biologists Workshops

For the last 15 years, our publisher, The Company of Biologists, has provided an apt environment to inspire biology and support biologists through our Workshops series. Read about the evolution of the Workshop series and revisit JEB's experience with hosting the first Global South Workshop.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
Propose a new Workshop for 2027

We are currently seeking proposals for Workshops to be held in 2027. As one of the scientific organisers of a The Company of Biologists Workshop, your involvement will be focused on interdisciplinary, cutting-edge science and promoting new partnerships and collaborations. We focus on the logistics. Are you thinking about proposing a topic for one of our Workshops? Apply by Friday 30 May 2025.